课题基金 / 基金详情

Developing combination therapies for telomerase-overexpressing clear cell carcinoma of the ovaries

Developing combination therapies for telomerase-overexpressing clear cell carcinoma of the ovaries
开发端粒酶过表达卵巢透明细胞癌的联合疗法
批准号：
475401
负责人：
Maranda Vincent
金额：
$7.65万
依托单位：
University of Saskatchewan
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475401&lang=en
关键词：
Clear Cell Carcinoma Mouse Models Ovarian Cancer Patient-Derived Xenografts Small Molecule Inhibitors Synthetic Lethality Telomerase

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer is a devastating disease affecting thousands of women every year in Canada. An estimated 3,000 Canadian women were diagnosed with ovarian cancer in 2022, and 1,950 have died from the disease. Ovarian cancer ranks fifth in cancer deaths amon
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金